Ultrasound and Peripheral Nerve Stimulator Guided Femoral Nerve Block

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital14 enrolled

Overview

A pre-post descriptive study was performed to examine the immediate effects of ultrasound (US) guided femoral nerve block with phenol (UGFNBwP) in managing lower limb spasticity of individuals with traumatic spinal cord injury (SCI).

Study Design: A pre-post descriptive study was performed. Objectives: To examine the immediate effects of ultrasound (US) guided femoral nerve block with phenol (UGFNBwP) in managing lower limb spasticity of individuals with traumatic spinal cord injury (SCI). Setting: Ankara, Turkey Methods: Nineteen patients with traumatic SCI presenting with lower extremity spasticity were treated with UGFNBwP. Modified Ashworth Scale (MAS) of hip flexion and knee extension, functional independence measure (FIM) motor subscale, difficulty of catheterization (DoC), hygiene score (HS), spasm frequency (SF), sleep quality (SQ) and patient satisfaction (PS) were measured in all patients prior to treatment, at first week and second month.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Spinal Cord Injuries

Interventions

Femoral nerve block with phenolOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Traumatic etiology * Duration of spinal cord injury more than twelve months * Spasticity of hip flexor and/or knee extensor muscle * Use of any oral medications to reduce spasticity at stable doses for at least one month before first assessment * The patients have to accept to continue same dose until end of the last assessment * Medical clearance to participate Exclusion Criteria: * Having established contracture of the knee/hip joint * Aged over 65 years * History of surgery for knee/hip disorders * Non-traumatic etiology

Outcomes

Primary Outcomes

Modified Ashworth Scale

Scale measures muscle tone (spasticity). (min-max:0-4).Higher values represent a worse outcome.

Time frame: up to 8 weeks

Secondary Outcomes

Functional independence measure

Scale measures level of independence on activities of daily life (min-max: 0-126) points).Motor subscale of FIM measure is used in this study (min-max:0-91). Higher values represent a better outcome.

Time frame: up to 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.